FLG rs2299007: Skin Barrier Function and Allergy Risk
rs2299007 is a common single nucleotide polymorphism located in the epidermal differentiation complex within the filaggrin (FLG) gene locus on chromosome 1. Research has linked this variant to alterations in transepidermal water loss and epidermal integrity, which may contribute to atopic dermatitis and subsequent allergic sensitization. While it modulates epithelial barrier dynamics, carrying the risk allele represents a predisposing factor rather than a direct diagnosis of skin disease or food allergies.
What each genotype means
Typical skin barrier function
You carry two copies of the common C allele. Published research associates this genotype with normal skin expression and baseline transepidermal water loss. In population studies, this genotype is not linked to increased risk of atopic dermatitis or associated secondary food allergies.
Carried by approximately 55% to 65% of individuals of European ancestry and is the predominant genotype across global populations.
Moderately increased water loss risk
You carry one copy of the T risk allele. Research indicates that this allele introduces a CpG methylation site that moderately downregulates skin barrier gene expression and increases transepidermal water loss. In population studies, this has been statistically associated with an increased susceptibility to childhood eczema and subsequent allergen sensitization.
Carried by approximately 30% to 35% of people of European ancestry.
Elevated skin barrier permeability risk
You carry two copies of the T risk allele. Studies show that having two copies is associated with higher local DNA methylation, decreased skin barrier integrity, and greater transepidermal water loss compared to other genotypes. This status correlates with a higher observed rate of atopic dermatitis and impaired barrier-related food allergen exposure in clinical cohorts.
Found in approximately 3% to 6% of individuals of European ancestry; it occurs at lower frequencies in East Asian and African ancestries.
Genomic Context and the Epidermal Differentiation Complex
The single nucleotide polymorphism rs2299007 is positioned on chromosome 1q21.3 within the epidermal differentiation complex (EDC). The EDC comprises a tightly clustered family of genes essential for terminal differentiation of keratinocytes and the maturation of the human skin barrier. Among these, the FLG gene encodes profilaggrin, an enormous, insoluble, highly phosphorylated polyprotein. In dbSNP, rs2299007 represents a base substitution involving cytosine and thymine alleles. Unlike severe loss-of-function null mutations (such as R501X or 2282del4) that completely disrupt profilaggrin expression, single nucleotide variations like rs2299007 typically exert subtle regulatory or modifier effects on gene expression, splicing, or protein processing within this dense genomic region. Because of high linkage disequilibrium across the EDC, individual SNPs often serve as genetic tags for broader regional haplotypes affecting epidermal protein scaffolding.
The Biological Function of Filaggrin
The FLG gene directs the production of profilaggrin, which is cleaved during epidermal cornification into individual filaggrin peptides. Filaggrin plays a pivotal architectural role by aggregating keratin intermediate filaments into dense parallel bundles, collapsing the granular cells into flattened squames that form the outermost protective layer of the skin, the stratum corneum. In subsequent stages, filaggrin undergoes enzymatic degradation into free amino acids, including pyrrolidone carboxylic acid and urocanic acid. These hygroscopic breakdown products constitute the primary components of natural moisturizing factor (NMF), which maintains skin hydration, regulates physiological cutaneous pH, and provides antimicrobial protection. Impairments anywhere along this biochemical pathway compromise structural tightness, accelerating transepidermal water loss (TEWL) and permitting irritants, microbes, and foreign antigens to penetrate the stratum corneum.
Clinical Research and Food Allergy Sensitization
Genome-wide and candidate-gene association studies have evaluated rs2299007 in cohorts assessing atopic dermatitis, dry skin traits, and systemic atopy. Published research suggests moderate association between this variant and elevated baseline transepidermal water loss, indicating micro-fissuring and diminished epidermal cohesion. Importantly, compromised skin barrier integrity serves as an entry route for epicutaneous sensitization, an immunological pathway highlighted in the dual-allergen exposure hypothesis. When environmental allergens, such as peanut or egg proteins, penetrate a disrupted cutaneous barrier rather than entering via the gut mucosal lining, skin-resident Langerhans cells and innate lymphoid cells frequently stimulate a pathogenic Th2 allergic response. Consequently, cohorts carrying barrier-weakening FLG variations demonstrate statistically elevated risks of developing secondary food allergies and asthma, often termed the atopic march.
Population Frequency and Ancestral Distribution
Allele distribution for rs2299007 shows noticeable variation across different global ancestries. In European populations, the minor allele is common, typically displaying a minor allele frequency (MAF) ranging between 0.15 and 0.25 in broad sequencing databases such as gnomAD and the 1000 Genomes Project. In East Asian, African, and South Asian reference groups, the allele frequencies may vary substantially or show divergent linkage patterns with neighboring functional variants. This ancestral diversity mirrors the broader genetic architecture of the FLG locus: while certain barrier-modifying variants are widespread in northern European descents, distinct sets of unique FLG variants predominate in Asian or African lineages, highlighting that skin barrier genetics must always be interpreted in an ancestry-specific context.
Practical Implications and Clinical Perspective
Understanding one's genotype at rs2299007 provides educational insight into baseline skin barrier physiology, but it cannot be used as a standalone diagnostic tool. Possessing one or two risk alleles does not guarantee that an individual will develop atopic dermatitis, dry skin, or childhood food allergies; conversely, having favorable alleles does not confer total immunity. Because skin disease and allergic sensitization arise from a complex interplay between dozens of genetic loci and environmental exposures—such as infant skin hydration routines, climate, detergents, and early dietary allergen introduction—genetic data simply highlights subtle susceptibility. Individuals concerned about eczema management, elevated skin dryness, or suspected food allergies should consult dermatologists and allergists for clinical skin examinations, diagnostic testing, and evidence-based topical care.
How common is this variant?
The rs2299007 minor allele is commonly observed in populations of European ancestry, where its minor allele frequency typically ranges between 0.15 and 0.25, while frequencies and linkage patterns vary across other ancestral groups.
Frequently asked questions
Does having the rs2299007 risk allele mean I will definitely develop a food allergy?
No. The presence of a risk allele at rs2299007 only indicates a statistical predisposition toward diminished skin barrier function, which can facilitate epicutaneous sensitization. Many individuals who carry this variant never experience atopic dermatitis or food allergies, as environmental factors, immune regulation, and early dietary habits play substantial roles.
How does a skin gene like FLG relate to allergic reactions to food?
The skin serves as a primary immunological defense against external antigens. When the skin barrier is leaky—such as through altered filaggrin expression—environmental food proteins can breach the stratum corneum and interact with cutaneous immune cells, triggering an allergic sensitization pathway rather than immune tolerance.
Can genetic testing for rs2299007 diagnose atopic dermatitis?
No, genetic testing for this single variant is not a diagnostic test for atopic dermatitis or eczema. Atopic dermatitis is diagnosed clinically by medical providers based on physical findings, clinical history, and symptom patterns, rather than single-gene testing.
Can moisturizers or skincare routines counteract the effects of this variant?
While genetics cannot be modified, proactive barrier repair using emollients and gentle skincare can physically support the stratum corneum and decrease transepidermal water loss. If you experience dry skin or eczema, discussing appropriate topical barrier-protective treatments with a dermatologist is recommended.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2299007?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FLG
A well-characterized loss-of-function null mutation (2282del4) in filaggrin predisposing individuals to cutaneous allergen penetration and the atopic march.
Loss-of-function variant (p.Lys501Ter) in FLG, a major predisposing factor for atopic dermatitis and ichthyosis vulgaris.
Filaggrin missense and splice-region variant associated with skin barrier disruption, atopic dermatitis, and allergic sensitization.
Loss-of-function mutation 2282del4 in filaggrin predisposing to peanut allergy.
Filaggrin coding variant associated with skin barrier disruption and allergic conditions.
A filaggrin locus variant associated with impaired epidermal barrier function, predisposing to atopic dermatitis and allergic sensitization.